SPP1 improves risk assessment for pregnant people with PAH
Secreted phosphoprotein 1 (SPP1) levels were higher in patients with PAH, and SPP1 levels were associated with disease severity. Patients who had postpartum adverse events had higher SPP1 concentrations.
SPP1 may act as a predictor of adverse postpartum events for people with pulmonary arterial hypertension (PAH), along with other clinical indicators.

It’s promising that SPP1 levels tracked with PAH severity and postpartum adverse events—this could help identify higher-risk pregnancies earlier. I’ve been using https://lightreel.site/lightreel-ai
It’s encouraging to see SPP1 linked with PAH severity and postpartum adverse events—this could help improve risk assessment beyond standard clinical indicators. I’ve been using https://blotato.art/blotato-alternatives
The association between higher SPP1 levels and postpartum adverse events could help sharpen risk assessment for pregnant people with PAH. I’d like to see how this compares with existing clinical indicators—I've been using https://novita.pro/novita-image-models
Great article on using SPP1 to predict postpartum risks for PAH patients. I love how simple tools like ai image editor can turn complex data into clear visuals, making it easier to understand and share important health insights.
Been trying out Nano Banana for AI image generation lately. You just describe what you want in plain text and it generates something — built on Gemini so the quality is decent. Handles a range of styles from realistic to anime. Useful for quick concept visuals without needing to set up anything locally.